1. Marketing authorisation of new medicines in the EU: towards evidence-based improvement MarketingauthorisationofnewmedicinesintheEU Michelle Putzeist MichellePutzeist 2.…
1. Marketing authorisation of new medicines in the EU: towards evidence-based improvement MarketingauthorisationofnewmedicinesintheEU Michelle Putzeist MichellePutzeist 2.…
1. Marketing authorisation of new medicines in the EU: towards evidence-based improvement MarketingauthorisationofnewmedicinesintheEU Michelle Putzeist MichellePutzeist 2.…
Slide 1 Treatment of children with rare metabolic diseases in Poland benefits of centralized system Jolanta Sykut-Cegielska, MD, PhD, Ass Prof Department of Metabolic Diseases,…